BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31165631)

  • 1. Quantifying time-varying cause-specific hazard and subdistribution hazard ratios with competing risks data.
    Diao G; Ibrahim JG
    Clin Trials; 2019 Aug; 16(4):363-374. PubMed ID: 31165631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parametric mixture models to evaluate and summarize hazard ratios in the presence of competing risks with time-dependent hazards and delayed entry.
    Lau B; Cole SR; Gange SJ
    Stat Med; 2011 Mar; 30(6):654-65. PubMed ID: 21337360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of censoring in competing risks analysis of the subdistribution hazard.
    Donoghoe MW; Gebski V
    BMC Med Res Methodol; 2017 Apr; 17(1):52. PubMed ID: 28376736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis and design of randomised clinical trials involving competing risks endpoints.
    Tai BC; Wee J; Machin D
    Trials; 2011 May; 12():127. PubMed ID: 21595883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two treatments in the presence of competing risks.
    Lyu J; Chen J; Hou Y; Chen Z
    Pharm Stat; 2020 Nov; 19(6):746-762. PubMed ID: 32476264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical recommendations for reporting Fine-Gray model analyses for competing risk data.
    Austin PC; Fine JP
    Stat Med; 2017 Nov; 36(27):4391-4400. PubMed ID: 28913837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The number of primary events per variable affects estimation of the subdistribution hazard competing risks model.
    Austin PC; Allignol A; Fine JP
    J Clin Epidemiol; 2017 Mar; 83():75-84. PubMed ID: 28088594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Communicating and understanding statistical measures when quantifying the between-group difference in competing risks.
    Wu H; Zhang C; Hou Y; Chen Z
    Int J Epidemiol; 2023 Dec; 52(6):1975-1983. PubMed ID: 37738672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring.
    Geskus RB
    Biometrics; 2011 Mar; 67(1):39-49. PubMed ID: 20377575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Goodness-of-fit test for monotone proportional subdistribution hazards assumptions based on weighted residuals.
    Boher JM; Filleron T; Giorgi R; Kramar A; Cook RJ
    Stat Med; 2017 Jan; 36(2):362-377. PubMed ID: 27790725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tree-based models for survival data with competing risks.
    Kretowska M
    Comput Methods Programs Biomed; 2018 Jun; 159():185-198. PubMed ID: 29650312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Misspecified regression model for the subdistribution hazard of a competing risk.
    Latouche A; Boisson V; Chevret S; Porcher R
    Stat Med; 2007 Feb; 26(5):965-74. PubMed ID: 16755533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysing and interpreting competing risk data.
    Pintilie M
    Stat Med; 2007 Mar; 26(6):1360-7. PubMed ID: 16900575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new measure of treatment effect in clinical trials involving competing risks based on generalized pairwise comparisons.
    Cantagallo E; De Backer M; Kicinski M; Ozenne B; Collette L; Legrand C; Buyse M; Péron J
    Biom J; 2021 Feb; 63(2):272-288. PubMed ID: 32939818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semiparametric accelerated failure time cure rate mixture models with competing risks.
    Choi S; Zhu L; Huang X
    Stat Med; 2018 Jan; 37(1):48-59. PubMed ID: 28983935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semiparametric competing risks regression under interval censoring using the R package intccr.
    Park J; Bakoyannis G; Yiannoutsos CT
    Comput Methods Programs Biomed; 2019 May; 173():167-176. PubMed ID: 31046992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating sample size in the presence of competing risks - Cause-specific hazard or cumulative incidence approach?
    Tai BC; Chen ZJ; Machin D
    Stat Methods Med Res; 2018 Jan; 27(1):114-125. PubMed ID: 26711503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the use of time-varying covariates in the Fine-Gray subdistribution hazard competing risk regression model.
    Austin PC; Latouche A; Fine JP
    Stat Med; 2020 Jan; 39(2):103-113. PubMed ID: 31660633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating and testing for center effects in competing risks.
    Katsahian S; Boudreau C
    Stat Med; 2011 Jun; 30(13):1608-17. PubMed ID: 21341296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysing multicentre competing risks data with a mixed proportional hazards model for the subdistribution.
    Katsahian S; Resche-Rigon M; Chevret S; Porcher R
    Stat Med; 2006 Dec; 25(24):4267-78. PubMed ID: 16960919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.